Soverini S; Rosti G; Iacobucci I; Baccarani M; Martinelli G., Choosing the Best Second-Line Tyrosine Kinase Inhibitor in Imatinib-Resistant Chronic Myeloid Leukemia Patients Harboring Bcr-Abl Kinase Domain Mutations: How Reliable Is the IC50?, «THE ONCOLOGIST», 2011, 16, pp. 868 - 876 [Scientific article]
Foà R; Vitale A; Vignetti M; Meloni G; Guarini A; De Propris MS; Elia L; Paoloni F; Fazi P; Cimino G; Nobile F; Ferrara F; Castagnola C; Sica S; Leoni P; Zuffa E; Fozza C; Luppi M; Candoni A; Iacobucci I; Soverini S; Mandelli F; Martinelli G; Baccarani M., Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, «BLOOD», 2011, 118, pp. 6521 - 6528 [Scientific article]
S Soverini; A Gnani; C De Benedittis; I Iacobucci; A Lonetti; C Papayannidis; L Potenza; M Luppi; S Merante; M Malagola; D Russo; M Tiribelli; M Salvucci; A Zaccaria; B Giannini; G Poletti; A Vitale; L Elia; M Vignetti; R Foà; M Baccarani; G Martinelli, Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2nd-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement, in: Blood, «BLOOD», 2011, 118 (21), pp. 575 - 575 (atti di: 53th ASH Annual Meeting, San Diego, California, December 10 - 13, 2011) [Abstract]
Anthony A. Oyekunle;Fausto Castagnetti;Gabriele Gugliotta;Simona Soverini;Michele Baccarani;Gianantonio Rosti, F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib, «LEUKEMIA RESEARCH», 2011, 35, pp. e118 - e120 [Scientific article]
Soverini S.; Score J.; Iacobucci I.; Poerio A.; Lonetti A.; Gnani A.; Colarossi S.; Ferrari A.; Castagnetti F.; Rosti G.; Cervantes F.; Hochhaus A.; Delledonne M.; Ferrarini A.; Sazzini M.; Luiselli D.; Baccarani M.; Cross NC.; Martinelli G., IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis., «LEUKEMIA», 2011, 25, pp. 178 - 181 [Scientific article]
Iacobucci I; Ferrari A; Papayannidis C; Lonetti A; Paoloni F; Trino S;
Abbenante M; Guadagnuolo V; Ottaviani; Cattina F; Vitale A;
Paolini S;Soverini S; Parisi S;Vignetti M; Baccarani M; Martinelli G, LOSS OF CDKN2A GENE IS A POOR PROGNOSTIC MARKER IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS, in: S3, «HAEMATOLOGICA», 2011, 96, pp. 43 - 43 (atti di: 43° Congresso Nazionale SIE, Napoli, Italy, October 16–18, 2011) [Abstract]
Soverini S; Gnani A; De Benedittis C; Castagnetti F; Gugliotta G; Iacobucci I; Palandri F; Rosti G; Testoni N; Luatti S; Marzocchi G; Baccarani M; Martinelli G, Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib, «LEUKEMIA RESEARCH», 2011, 35, pp. 1527 - 1529 [Scientific article]
Iacobucci I; Ferrarini A; Sazzini M; Lonetti A; Ferrari A;
Papayannidis C; Soverini S; Xumerle L; Guadagnuolo V; Trino S;
Cattina F; Pane F; Baccarani M; Russo D; Delledonne M; Martinelli G, NEXT GENERATION PAIRED END TRANSCRIPTOMIC RE-SEQUENCING TECHNOLOGY REVEALS NOVEL COMMON GENETIC ALTERATIONS IN THE HEDGEHOG PATHWAY IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), in: S3, «HAEMATOLOGICA», 2011, 96, pp. 166 - 167 (atti di: 43° Congresso Nazionale SIE, Napoli, Italy, October 16–18, 2011) [Abstract]
Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobucci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G, Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients., in: Abstract book, London, United Kingdom, 2011, 96(s2), pp. 51 - 51 (atti di: 16^ Congress of the European Hematology Association, London, UK, 9-12 Giugno 2011) [Abstract]
Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli, PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients, «BLOOD», 2011, 118, pp. 1429 - 1429 [Abstract]
Soverini S; Vitale A; Poerio A; Gnani A; Colarossi S; Iacobucci I; Cimino G; Elia L; Lonetti A; Vignetti M; Paolini S; Meloni G; di Maio V; Papayannidis C; Amabile M; Guarini A; Baccarani M; Martinelli G; Foa' R, Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis, «HAEMATOLOGICA», 2011, 96, pp. 552 - 557 [Scientific article]
A Ferrari ;I Iacobucci ;M Sazzini ;A Lonetti ;A Boattini ;C Papayannidis ;P Garagnani ;MC Abbenante ;V Mantovani ;F Cattina ;E Marasco ;E Ottaviani ;S Paolini ;D Girelli ;M Vignetti ;F Pane ;S Soverini ;M Baccarani ;G Martinelli, THE RS564398, A POLYMORPHISM IN “THE ANTISENSE NON-CODING RNA IN THE INK4 LOCUS”, ANRIL, IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) SUSCEPTIBILITY, in: S2, «HAEMATOLOGICA», 2011, 96, pp. 2 - 3 (atti di: 16th Congress of European Hematology Association, London, United Kingdom, June 9-12, 2011) [Abstract]
Ilaria Iacobucci, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, Giovanni Martinelli, TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia, «BLOOD», 2011, 118 (21), Article number: 1484 , pp. 1484 - 1484 [Abstract]
Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Brighenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli, The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL), «BLOOD», 2011, 118, Article number: 76 , pp. 76 - 76 [Abstract]
Iacobucci, I.; Ferrari, A.; Lonetti, A.; Papayannidis, C.; Paoloni, F.; Abbenante, M.; Guadagnuolo, V.; Ottaviani, E.; Cattina, F.; Vitale, A.; Paolini, S.; Soverini, S.; Parisi, S.; Vignetti, M.; Baccarani, M.; Martinelli, G., The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL), in: J Clin Oncol 29: 2011 (suppl; abstr 6532), «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 6532 - 6532 (atti di: 47th ASCO Annual Meeting, Chicago, Illinois., June 3-7, 2011) [Abstract]
